Investigators designed and externally validated a prostate cancer death prediction model for risk stratification of men at the point of PSA screening.

A new long-term prediction tool estimates the risk of dying from prostate cancer, offering a more accurate way to interpret ...

Benign prostate hyperplasia (BPH) is a non-cancerous enlargement of the prostate gland, which is generally the shape and size ...

University Hospitals Seidman Cancer Center researchers have developed a tool that could identify metastatic prostate cancer ...

To help meet the potentially complex needs of patients after prostate cancer treatment and offer the precision and care ...

Editor's note: Dr. Jamin Brahmbhatt is a urologist and robotic surgeon with Orlando Health and an assistant professor at the University of Central Florida’s College of Medicine.When I learned that ...

Model was developed from the prostate cancer screening group of the PLCO and validated externally in a VA population ...

Anyone discouraged by the continued absence of a prostate cancer screening programme, the difficulties in getting a clear ...

News that former President Joseph Biden has advanced prostate cancer has revived long-standing questions about the benefits versus the harms of a blood test that screens for the most commonly ...

Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the first patient in the United States (U.S.) has been dosed in BiPASS™ (Bi opsy of the P rostate A voidance S ...

Prostate cancer is the most common cancer in men, with about 1-in-8 expected to be diagnosed in their lifetime.